Prior to joining Ballast Point Ventures, Matt worked in the Strategic Alliances group at the Novartis Institutes for BioMedical Research. He also served as an Analyst in the Health Care Investment Banking Group at Raymond James where he focused primarily on the specialty pharmaceutical, drug distribution and contract research organization sectors. Matt spent two years at Ballast Point Ventures as a Senior Associate prior to attending business school.
He graduated from the University of Virginia with a bachelor’s degree in Commerce and from the Harvard Graduate School of Business Administration with an MBA.
Matt currently serves on the board of directors at Iconixx, MolecularMD, TissueTech and Y-Prime, and previously represented BPV at Innocutis.